Mark Cuban calls Yusimry’s availability on MCCPDC ‘a game changer’

Mark Cuban Cost Plus Drug Company (MCCPDC) announced it is working with Coherus Biosciences, Inc. to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price. 

Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s disease and plaque psoriasis.

The medication will be available through MCCPDC starting July 2023, costing $569.27 plus dispensing and shipping fees. It will be the first biologic product offered by the discount drug supplier. 

In February, MCCPDC announced a new program on Twitter, aiming to create an independent pharmacists’ network where members would be provided a “Team Cuban Benefits Card.” MCCPDC said in a statement that Yusimry would be included in the benefits program through participating pharmacies. 

“Coherus’s Yusimry is a game changer. Having an alternative to Humira that is affordable will improve the lives of patients everywhere. is truly excited to make Yusimry available to everyone in a transparent manner,” Mark Cuban told MobiHealthNews in an email. 


Since MCCPDC’s launch in 2022, it’s developed numerous partnerships and collaborations.

In April, the company announced a collaboration with Seattle-based Zócalo Health, a virtual healthcare service for Latino patients, to expand Zócalo members’ access to lower-cost prescription medication. 

That same month, Fierce Healthcare reported MCCPDC teamed up with RevSpring, a health payment solutions company, to run a program with U.S. pharmacies to make drugs more affordable for consumers. 

MCCPDC has also established partnerships with California-based EmsanaRx and Tennessee-based RxPreferred Benefits and announced collaborations with diabetes and chronic disease management company Diathrive Health and cancer care support company OncoPower.

MCCPDC was also integrated into Rightway Health‘s platform, allowing the pharmacy benefit manager’s members access to MCCPDC. 

Last year, the company also announced its first health plan partnership with Capital Blue Cross, noting Capital’s members could use their insurance cards at MCCPDC directly as of the start of 2023.



About Author

You may also like


Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties